Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program| (NASDAQ: DTIL) | Delayed: 7.29 +0.54 (8.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.75 | 52 Week High | $ | |||
| Open | $6.73 | 52 Week Low | $ | |||
| Day High | $7.60 | P/E | N/A | |||
| Day Low | $6.73 | EPS | $ | |||
| Volume | 3,340,822 | |||||

